Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: TDA RESEARCH, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-07-11 to 2027-11-08
Current total value of award: $1299965.51
Description: DHA PHASE II SBIR CONTRACT FOR PSORALEN-UV-A INACTIVATION BASED HIGH-THROUGHPUT PATHOGEN INACTIVATION DEVICE